Citation Impact
Citing Papers
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
2002
Partial Response and Nonresponse to Antidepressant Therapy
2002
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: A Literature Review and a Proposal for a Novel Approach to Improve Practice
2006
Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants
2010
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment
2010
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
1996
Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics
2003
Depression
2018 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study
2003
Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging
1999
Diffusion tensor imaging: Concepts and applications
2001 Standout
Fiber tracking: principles and strategies – a technical review
2002 Standout
The spectrum of neuromyelitis optica
2007 Standout
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
2006 Standout
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
1997
North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care
1999
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
Quantitative assessment of MRI lesion load in multiple sclerosis: A comparison of conventional spin-echo with fast fluidattenuated inversion recovery
1996
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
2009 Standout
Who Responds to Electroconvulsive Therapy?
1996
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology
2012
The adolescent brain and age-related behavioral manifestations
2000 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Platelet serotonin and [ 3 H]paroxetine binding correlate with recurrence of suicidal behavior
1997
A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis
2005
Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis
2006
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Immunopathology of multiple sclerosis
2015 Standout
Sequence-independent segmentation of magnetic resonance images
2004 Standout
The Serotonin Syndrome
2005 Standout
A review of MRI findings in schizophrenia
2001 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Evaluation of the antidepressant activity of Moringa oleifera alone and in combination with fluoxetine
2015 Standout
Are All Antidepressants Really the Same? The Case of Fluoxetine
2006
Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification
2007 Standout
Clinical Neuroimaging in Psychiatry
1995
Whole Brain Segmentation
2002 Standout
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis
2000
Establishing norms for age-related changes in proton T1 of human brain tissue in vivo
1997
Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability
2003
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs
2000
Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression
2000
"Wish Bias" in Antidepressant Drug Trials?
2004
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
2003 Standout
Diffusion Tensor Imaging of the Brain
2007 Standout
Industry sponsorship and research outcome
2012 Standout
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Fluoxetine versus other types of pharmacotherapy for depression
2013
Alzheimer's disease
1998 Standout
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
National Service Framework for Mental Health
2000 Standout
Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence.
1997
Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions.
1999
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
A review of depression and suicide risk assessment using speech analysis
2015 Standout
Industry sponsorship and research outcome
2017 Standout
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica
1999
Works of Toni Lock being referenced
Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the “invisible” lesion load
1994
Predictors of response to amine-specific antidepressants
1995
Placebo-Controlled Trial of Lithium Augmentation of Fluoxetine and Lofepramine
1995
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine
1994
Local cerebral glucose utilization after chronic electroconvulsive shock: implications for the mode of action of electroconvulsive therapy
1991
A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness
1994
Psychiatry and the New Magnetic Resonance Era
1990